Evidence map›Paper›PMID 41632719›Full record

ArticlePLoS medicine2026

The mpox epidemic is not over: Reducing disproportionate burden in Africa and persistent global risk require a sustained response.

Dieudonné Mwamba Kazadi, Rosamund F Lewis, Pierre Akilimali, Danny Kalala, Maria Van Kerkhove, Chikwe Ihekweazu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PLoS medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dieudonné Mwamba KazadiInstitut National de Santé Publique, Ministère de la Santé publique, de l'Hygiène et de la Prévoyance sociale, Kinshasa, République Démocratique du Congo.ORCID https://orcid.org/0000-0002-4676-2495
Rosamund F LewisHealth Emergencies Preparedness and Response Programme, World Health Organization, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-7227-2545
Pierre AkilimaliInstitut National de Santé Publique, Ministère de la Santé publique, de l'Hygiène et de la Prévoyance sociale, Kinshasa, République Démocratique du Congo.ORCID https://orcid.org/0000-0002-3828-6214
Danny KalalaInstitut National de Santé Publique, Ministère de la Santé publique, de l'Hygiène et de la Prévoyance sociale, Kinshasa, République Démocratique du Congo.ORCID https://orcid.org/0009-0007-0461-608X
Maria Van KerkhoveHealth Emergencies Preparedness and Response Programme, World Health Organization, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-6135-0018
Chikwe IhekweazuHealth Emergencies Preparedness and Response Programme, World Health Organization, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While global interest in mpox may be waning, outbreaks, illness, and death continue across Africa and the world. Ending transmission requires a sustained global response that moves beyond reactive measures.

Indexed as

Disease OutbreaksEpidemicsGlobal HealthMpox, MonkeypoxAfricaHumans

Identifiers

PMID41632719
PMCPMC12867245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.